Total Midline & PICC Units Sold, by Type, U.S., 2014-2016ĭiminished PICC Insertions Soften Tip-Placement Device Market on an annual basis, movement of this magnitude translates to robust midline unit sales growth. With over 3 million PICCs placed in the U.S. Increasing adherence to new appropriate usage guidelines, among other factors, is expected to drive this rate to reach about 15 percent by the end of 2016. In 2015, midlines represented approximately 10 percent of combined midline and PICC unit sales in the United States. Quantifying The Shifting Mix Of Vascular Access Devices Infusion Nursing Standards of Practice, in contrast, does not rule out the use of a midline. 9 Under this criteria, administering vancomycin, which has a pH of 3.9, would have typically required the placement of a PICC. Previous editions of the Infusion Nursing Standards of Practice have stated that infusates with a pH outside the recommended range of 5 to 9 should not be administered through a midline. One such scenario is the short-term intravenous administration of vancomycin, a widely used antibiotic. 8,9 This change increases the volume of scenarios in which the use of a midline is appropriate. 1,8,9 Most notably, pH alone is no longer an indication for the use of a central line. The midline market is expected to gain additional momentum from the release of the INS’s 2016 Infusion Nursing Standards of Practice, which, relative to previous editions, includes reduced limitations on drugs and solutions administered through midlines. 7 Use of the MAGIC assessment tool is expected to increase over the next seven years, driving a shift in vascular access device usage from PICCs to midlines. 6 A recent application of the MAGIC assessment tool in one facility yielded a 35 percent decline in monthly PICC insertions, while monthly midline insertions almost tripled. Released in September 2015, the Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) is a collection of guidelines providing recommendations as to when one vascular access device is preferable to another. While reimbursement changes have shaped the trajectory of the midline market in recent years, future growth will be driven by the adoption of recently published appropriate usage guidelines from the University of Michigan and the INS. Midlines, with an estimated infection rate well below that of PICCs, have come into vogue, offering an attractive alternative to PICCs in select cases. 2,3 In the wake of this decision, healthcare providers have placed increased weight on selecting the vascular access catheter with the lowest associated infection rate. In 2008, CMS discontinued payment for the estimated $32,000 cost tied to treating a central line-associated blood stream infection. The uptick in midline insertions is exerting downward pressure on PICC sales, which, in turn, is contributing to moderation in the tip-placement device market. ![]() However, recent initiatives from the Centers for Medicare and Medicaid Services (CMS), as well as new appropriate usage guidelines from the University of Michigan and Infusion Nursing Society (INS), are driving a surge in midline use. ![]() Traditionally, midlines have occupied a niche market between peripherally inserted central catheters (PICCs) and peripheral intravenous catheters (PIVCs). Midline catheters are used to obtain short- to intermediate-term peripheral venous access for infusing intravenous fluids and medication. ![]() By Kamran Zamanian, Ph.D., and Sean Collins, iData Research Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |